IRIS International, Inc. (Nasdaq:IRIS) a leading manufacturer of urinalysis systems and consumables for use in hospitals and commercial laboratories worldwide, today announced a new supply agreement for its full product line of automated and semi-automated urinalysis systems, related products, consumables and services agreements, with Amerinet Inc., a leading national healthcare group purchasing organization (GPO) servicing more than 41,000 provider facilities, including 2,537 acute care hospitals. The new three-year sales and service supply agreement went into effect June 1, 2010.
"We are pleased to renew our supply agreement with Amerinet, one of the largest GPOs in the country. Since beginning our partnership with Amerinet in June 2007, the installed base of IRIS instrumentation within the Amerinet membership has grown by more than 400%, representing a vital sales channel for our urinalysis systems and consumables," stated Thomas E. Warekois, President of the Iris Diagnostics Division. "We look forward to continuing our strong strategic partnership with Amerinet in the years ahead, and to bringing laboratory automation to an increasing number of its members," he added.
SOURCE IRIS International, Inc.